This Non-Disclosure & Confidentiality Agreement (this “Agreement”) is entered into and effective as of the date of acceptance, by and between PathMDAI, Inc., a Delaware corporation (the “Company”), and [your name] (the “Recipient”), reachable at [your email].
The Recipient will receive the Company's investor deck, financial model, and regulatory, clinical, legal and technical materials (the “Confidential Information”), disclosed solely so the Recipient may evaluate a potential investment in the Company (the “Permitted Purpose”).
The Recipient will use the Confidential Information only for the Permitted Purpose and will disclose it only to the Recipient's advisors and fund colleagues on a need-to-know basis, each bound by confidentiality obligations at least as protective as these.
Nothing here restricts the Recipient from evaluating or investing in other companies, provided the Confidential Information is not used or disclosed.
The Confidential Information is provided for information only and does not constitute an offer to sell, or the solicitation of an offer to buy, any security.
The Recipient's confidentiality obligations continue for three (3) years from the date of acceptance.
This Agreement is governed by the laws of India; any dispute will be resolved by arbitration seated in India.
The Recipient represents and acknowledges that: (a) it received access to these materials through a direct, personal communication and not as a result of any general solicitation, public advertisement, or offer made to the public; (b) it is a sophisticated party able to evaluate and bear the risks of a potential investment of this nature and, where applicable, qualifies as an accredited or otherwise eligible investor under applicable law; (c) it is reviewing these materials solely to evaluate a potential investment for its own account; (d) it understands these materials are not an offer to sell or a solicitation to buy any security, and any offering will be made only to eligible investors through definitive transaction documents; and (e) it will not forward, post, or otherwise make these materials or the access link available to the public or to anyone other than its own advisors on a need-to-know basis.
By typing your name and clicking “Agree & enter,” you confirm you are authorised to accept on behalf of the Recipient and that your typed name and click constitute a valid, binding electronic signature under applicable law, including the Information Technology Act, 2000.